Clinical trial
Comparison of Standard Versus High Dose Urokinase for Dysfunctional Tunneled Dialysis Catheters in Haemodialysis Patients: A Randomized Controlled Trial
NCT06802679 is registered in ClinicalTrials.gov with National Healthcare Group, Singapore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Standard Versus High Dose Urokinase for Dysfunctional Tunneled Dialysis Catheters in Haemodialysis Patients: A Randomized Controlled Trial
- Lead sponsor
- National Healthcare Group, Singapore
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 1, 2020
- Completion date
- January 27, 2025
- Enrollment
- 44 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dialysis access dysfunction, end stage renal disease (esrd), hemodialysis, randomised controlled trial, thrombolytic therapy